Tag Archive for Financial Reports

Zinzino Preliminary Sales Report 2025

Zinzino group revenue increased 46% in Q4 and total revenue for the full year 2025 increased 51%, compared with the previous year.
The revenue in December for Zinzino‘s sales markets increased by 35% and amounted to SEK 334.4 (246.9) million. Faun Pharma’s external sales decreased and amounted to SEK 2.9 (5.8) million. Overall, the Group increased revenues by 33% to SEK 337.3 (252.7) million compared with the previous year.
Revenue in Zinzino’s sales markets increased by 50% in the fourth quarter of 2025 compared with the same period last year and amounted to SEK 1,032.3 (690.3) million. Total revenues in the Group increased by 46% in the fourth quarter and amounted to SEK 1,042.4 (713.5) million.
Accumulated revenue for January – December 2025 increased by 51% to SEK 3,344.5 (2,207.8) million.
Revenues were distributed as follows:

Regions, mSEK
25-Dec
24-Dec
Change
Q4 2025
Q4 2024
Change
YTD 2025
YTD 2024
Change

The Nordics
31.4
29.6
6%
98.4
88.0
12%
332.5
302.0
10%

Central Europe
102.9
78.1
32%
337.9
202.3
67%
995.4
596.7
67%

East Europe
36.3
34.5
5%
122.0
120.6
1%
398.0
400.4
-1%

South & West Europe
53.7
49.7
8%
167.8
131.9
27%
565.8
396.4
43%

The Baltics
18.0
12.0
50%
48.3
38.2
26%
133.5
107.6
24%

North America
52.0
21.1
146%
163.8
66.3
147%
545.7
200.5
172%

Asia-Pacific
37.4
20.2
85%
86.2
37.1
132%
299.4
84.6
254%

Africa
2.7
1.7
59%
7.8
5.9
32%
23.8
16.8
42%

Zinzino
334.4
246.9
35%
1,032.3
690.3
50%
3,294.1
2,105.0
56%

Faun Pharma
2.9
5.8
-50%
10.1
23.2
-57%
50.4
102.8
-51%

Zinzino Group
337.3
252.7
33%
1,042.4
713.5
46%
3,344.5
2,207.8
51%

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
Asia-Pacific: Australia, New Zealand, Hong

Read more...

Bravenly Global Surpasses $100 Million in Annual Sales in 2025, Marking a Major Milestone in Just 5 Years

Bravenly Global announced today that it has surpassed $100 million in 2025 sales revenue, reaching this 9-figure annual milestone in just five years since its founding. 
In achieving their stated 2025 goal, Bravenly continues the trend of more than doubling again this year:  from $8.5 million in 2022, to $19 million in 2023, to over $50 million in 2024 – and now over $100 million in 2025. 
The achievement comes as Bravenly continues to grow organically across the United States. Aspen Emry, Co-Founder and CEO, shared:

“This milestone belongs to our Brand Partners. From the very first people who said ‘yes’, to the leaders who have poured their hearts into serving others, to the person who just joined and is bravely taking a first step – every single one of you matters more than you know. Bravenly exists because of your courage, your consistency, your faith, and your willingness to believe again. I’m deeply grateful for the trust you place in us, humbled by the lives you touch every day, and committed to honoring what you’re building for your families. This company was never about numbers – it’s about people – and I carry that responsibility with love, reverence, and gratitude every single day.”

A Milestone Built on

Read more...

Zinzino Sales Growth November 2025

Zinzino AB (PUBL.): Preliminary Sales Report November 2025

Zinzino group revenue increased with a total of 45 %, compared with the previous year. The revenue in November for Zinzino’s sales markets increased by 49 % and amounted to SEK 375.0 (251.8) million. Faun Pharma’s external sales decreased and amounted to SEK 4.3 (10.1) million.
Overall, the Group increased revenues by 45 % to SEK 379.3 (261.9) million compared with the previous year.
Accumulated revenue for January – November 2025 increased by 54 % to SEK 3,007.5 (1,955.1) million.
Revenues were distributed as follows:

Regions, MSEK
25-Nov
24-Nov
Change
YTD 2025
YTD 2024
Change

The Nordics
29.7
29.0
2%
301.0
272.3
11%

Central Europe
133.9
70.4
90%
892.2
518.7
72%

East Europe
51.5
51.6
0%
361.9
366.0
-1%

South & West Europe
58.7
45.3
30%
513.9
346.7
48%

The Baltics
17.3
16.1
7%
115.4
95.6
21%

North America
58.1
25.8
125%
491.0
179.2
174%

Asia-Pacific
23.0
11.1
107%
263.7
64.4
309%

Africa
2.8
2.5
12%
21.1
15.1
40%

Zinzino
375.0
251.8
49%
2960.2
1858.0
59%

Faun Pharma
4.3
10.1
-57%
47.3
97.1
-51%

Zinzino Group
379.3
261.9
45%
3007.5
1955.1
54%

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
Africa: South Africa

View as PDF
SOURCE: Zinzino
About Zinzino
Zinzino AB (publ) (ZZ-B.ST) is a global direct-sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier

Read more...

Bravenly Global Announces Largest Month Ever in Company’s History

Bravenly Global is thrilled to announce that November 2025 marked the largest revenue month in the company’s almost five-year history, marking a defining moment of momentum and growth for the renowned family-owned health and wellness brand.
Largest Month, Consistent Growth
This milestone continues a consistent pattern of growth for Bravenly throughout 2025 and over the past three years – 3,009% as recognized by Inc. 5000. Year over year, the company has demonstrated rising customer demand, expanding field leadership, and strong, steady upward trajectory — on track to double again this year, growing from over $50 million in 2024 to $100 million in 2025.
After an exciting Black Friday, in which almost 2,000 new Customers and Brand Partners joined Bravenly and over $3.6 million in sales achieved in 24 hours, Bravenly continues to track with their 2025 goal. Customers continue to comprise over 80% of Bravenly’s total consumer base. Together with Black Friday weekend, Bravenly leaders noted that the record-breaking month was also fueled by consistency and growth following Bravenly’s October Leadership Summit in Orlando, FL. In the weeks since then, leaders have reported stronger activity, rising consumer demand, and growth across the board.

“What we saw in November was the result of steady, purposeful

Read more...

LR Health & Beauty Publishes Final Q3 2025 Results

28 November 2025 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today published its final results for the third quarter of 2025 and the first nine months of 2025, thereby confirming the preliminary figures announced on 24 October 2025.

Preliminary figures for Q3/9M 2025 confirmed: sales for 9M 2025 at EUR 208.8 million, EBITDA reported at EUR 16.3 million
Focus on initiatives to optimise business processes and sustainably improve the capital and financing structure
Forecast for the 2025 financial year confirmed

View Q3 Interim Report

In the third quarter of the 2025 financial year, LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 66.0 million (previous year: EUR 69.4 million), bringing sales for the first nine months of 2025 to EUR 208.8 million (previous year: EUR 212.7 million). While market conditions in many regions remained characterized by weak consumer sentiment, two newly launched fragrance collections provided positive momentum in September.
EBITDA reported for the third quarter of 2025 amounted to EUR 2.9 million (Q3 2024: EUR 7.3 million), primarily impacted by lower sales and higher marketing and sales expenses. Consequently, EBITDA reported for the first nine months of 2025 came in

Read more...

Special Report Shows How Middle-Income Families Are Navigating the ‘Inflation Hangover’

According to a recent Primerica press release:
Higher cost of living keeps squeezing household budgets — but professional financial guidance is helping families regain control and build resilience.
The road to financial recovery may be long, but middle-income families are proving resilient as they adapt to higher costs and redefine their financial goals, according to a new special report from Primerica, Inc. (NYSE: PRI), a leading provider of financial products and services to middle-income families. Titled  “The Inflation Hangover: Middle-Income Americans Build Resilience on the Long Road to Recovery,” the report offers an in-depth look at how middle-income households are adapting to the long-term effects of inflation and the factors that are helping them regain financial stability.
Drawing on the company’s Financial Security Monitor™ (FSM™) survey and Household Budget Index™ (HBI™) data, the report finds that the higher cost of living continues to ripple through household budgets, even though inflation has eased significantly from its 2022 peak. Families report tapping savings, relying more heavily on credit cards and delaying contributions to retirement plans — all of which create long-term gaps that are difficult to close.
Read Primerica’s report: How Middle-Income Families Are Navigating the ‘Inflation Hangover’

“Inflation may have slowed, but the financial hangover it created is

Read more...

Zinzino Interim Report For Q3 2025

Strong sales growth and increased profit margins drive profitability upwards
To view the full report, go to: Zinzino Interim Report Q3 2025
Revenue for the third quarter of 2025 amounted to SEK 784.1 (532.8) million, corresponding to 47% (22%) growth compared with the same period last year. In local currencies, revenue for the third quarter increased by 53% compared with the corresponding period last year.
EBITDA increased to SEK 109.7 (63.0) million after the EBITDA margin increased to 14.0% (11.8%).
The improved EBITDA margin compared to the corresponding period last year was mainly due to stronger gross profit and increased synergies, primarily related to the acquisition of Zurvita.
During the quarter, Zinzino also acquired the assets of the US-based direct sales companies Bodē Pro and Truvy to increase distribution power in North America, Latin America, South Korea and Japan.
JULY-SEPTEMBER 2025

Total revenue amounted to SEK 784.1 (532.8) million, corresponding to a growth of 47% (22%)
Gross profit amounted to SEK 277.2 (178.8) million and the gross profit margin was 35.4% (33.6%)
EBITDA amounted to SEK 109.7 (63.0) million and the EBITDA margin was 14.0% (11.8%)
Net profit amounted to SEK 89.4 (42.6) million
Net profit per share after tax before dilution amounted to SEK 2.47 (1.24)
Cash flow from operating activities

Read more...

Mannatech Reports Financial Results for Third Quarter 2025

Mannatech Announces Q3 2025 Results Highlighting Margin Improvements and Stronger Profitability
Mannatech, Incorporated has released its financial results for the third quarter of 2025, reporting notable gains in margins and profitability, with Asia-Pacific continuing to be the strongest region for the company. Gross profit as a percentage of net sales rose to 76.4%, supported by pricing adjustments, efficient inventory management, and the timing of promotional activities.
Operational performance also strengthened. Income from operations increased to $2.0 million, more than double the prior-year period, while net income reached $1.9 million, or $1.01 per diluted share, compared to a loss in Q3 2024.
Asia-Pacific remained the company’s leading region, generating $18.8 million, or more than 64% of total quarterly revenue, followed by $7.9 million from the Americas.
Mannatech reported 119,000 active associate and preferred customer positions, with Asia-Pacific continuing to be the most consistent region for ongoing activity.
Net sales for the quarter totaled $29.2 million, compared to $31.7 million in the same period of 2024 — a change the company attributes to slowing demand in certain regions.
Importantly, the company noted that Q3 sales exceeded the first two quarters of 2025, indicating improved momentum as the year progressed.
Mannatech closed the quarter with $7.1 million in cash and cash

Read more...

Nu Skin Enterprises Reports Third Quarter Earnings

Company preparing for limited introduction of Prysm iO and pre-market opening of India in the fourth quarter
Nu Skin Enterprises Inc. (NYSE: NUS) announced third quarter revenue and earnings per share within its guidance range.
Ryan Napierski, Nu Skin president and CEO, stated:

“We are pleased with our third quarter results, which were in line with expectations, as we continue to navigate a challenging macro environment while preparing for the introduction of our intelligent wellness platform.

“Our Latin America region once again delivered strong, double-digit year-over-year growth, and we’re encouraged by positive trends such as sequential growth in several of our reporting segments. Through disciplined execution and operational efficiency, we delivered earnings per share at the high end of our guidance range.”

Napierski continued:

“As we look ahead, there is growing excitement and energy for the upcoming launch of our Prysm iO intelligent wellness platform and our expansion into India – two pivotal milestones that will accelerate our vision to become the world’s leading intelligent beauty and wellness company. Our leaders are eager to begin building with Prysm iO with a limited sales leader preview in late Q4 followed by broader sales leader availability and a full consumer launch in 2026. We believe our AI-powered wellness

Read more...

Coway Announces Financial Results for Q3 FY2025

Coway Co., Ltd., the “Best Life Solution Company,” has today released its financial results for the third quarter of 2025.

“Strong sales of our leading home environment appliances, along with the steady growth of our BEREX lineup of beds and massage chairs, have driven overall performance this quarter,”

said Soon Tae Kim, Coway‘s Chief Financial Officer.

“Building on this core business competitiveness, we will continue to strengthen our future growth drivers and sustain balanced momentum across both domestic and global markets going forward.”

Coway Financial Results
Coway’s reported earnings are as follows:

Third quarter revenue: KRW 1,254.4 billion (+14.0% YoY)
Third quarter operating profit: KRW 243.1 billion (+17.4% YoY)

* The reported figures are taken from the consolidated K-IFRS (International Financial Reporting Standards) statement.

Coway’s cumulative revenue for 2025 has now reached KRW 3,688.2 billion (+15.8% YoY), with an operating profit of KRW 697.0 billion (+13.9%).
Within the domestic market, Coway achieved a third-quarter revenue of KRW 740.2 billion, a 12% increase when compared with the same period last year. This strong performance was driven by robust sales of the new Icon Ice Water Purifier series, which features three models and has been designed to meet diverse capacity needs, from compact to large. Thanks to this addition to the

Read more...